The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Nosulia E.V.

Medically-induced rhinitis

Authors:

Nosulia E.V.

More about the authors

Journal: Russian Bulletin of Otorhinolaryngology. 2017;82(3): 84‑90

DOI: 10.17116/otorino201782384-90

Read: 3849 times

Download PDF (RU)
Contact the author
Table of contents

MEDICALLY-INDUCED RHINITIS
MEDICALLY-INDUCED RHINITIS

To cite this article:

Nosulia EV. Medically-induced rhinitis. Russian Bulletin of Otorhinolaryngology. 2017;82(3):84‑90. (In Russ.)
https://doi.org/10.17116/otorino201782384-90

Подписка 2026 Вестник оториноларингологии (Russian Bulletin of Otorhinolaryngology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Deve­lopment of an expe­rimental rabbit model of rhinitis medi­camentosa. Russian Bulletin of Otorhinolaryngology. 2025;(3):46-52
Abstract:

This paper summarizes the currently accepted concepts of the pathogenetic mechanisms underlying the morphological and functional changes in intranasal mucosa of the patients having a long history of the application of the long-acting topical vasoconstrictor agents. The author presents the data illustrating the effectiveness of various methods for the pharmacotherapeutic treatment of medically-induced rhinitis.

Keywords:

topical decongestants
medically-induced rhinitis

Authors:

Nosulia E.V.

Close metadata

References:

  1. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006;16(3):148-155.
  2. Graf P. Rhinitis medicamentosa: aspects of pathophysiology and treatment. Allergy. 1997;52(40 suppl):28-34.
  3. Fleece L, Mizes JS, Jolly PA, Baldwin RL. Rhinitis medicamentosa Conceptualization, incidence, and treatment. Ala J Med Sci. 1984;21:205-208.
  4. Archontaki M, Symvoulakis EK, Hajiioannou JK, Stamou AK, Kastrinakis S, Bizaki AJ, Kyrmizakis DE. Increased frequency of rhinitis medicamentosa due to media advertising for nasal topical decongestants. B-ENT. 2009;5(3):159-162.
  5. Toohill RJ, Lehman RH, Grossman TW, Belson TP. Rhinitis medicamentosa. Laryngoscope. 1981;91(10):1614-1621.
  6. Feinberg A, Feinberg S. The «nose drop nose» due to oxymetazoline (Afrin) and other topical vasoconstrictors. IMJ III Med J. 1971;140:50-52.
  7. Mizobe T, Maze M. Alpha 2-adrenoceptor agonists and anesthesia. Int Anesthesiol Clin. 1995;33(1):81-102.
  8. Scadding GK. Rhinitis medicamentosa. Clin Exp Allergy. 1995;25(5):391-394.
  9. Kai T. Effects of topical alpha 1- and beta 2-adrenoceptor stimulants on nasal nitric oxide level. Nippon Jibiinkoka Gakkai Kaiho. 1999;102:7:898-906.
  10. Westerveld GJ, Voss HP, van der Hee RM. Inhibition of nitric oxide synthase by nasal decongestants. Eur Respir J. 2000;16:3:437-444.
  11. Schlosser RJ, Spotnitz WD, Peters EJ, et al. Elevated nitric oxide metabolite levels in chronic sinusitis. Otolaryngol Head Neck Surg. 2000;123:4:357-362.
  12. Freeman B. Free radical chemistry of nitric oxide: Looking at the dark side. Chest. 1994;84.
  13. Pasto M, Serrano E, Urocoste E, et al. Nasal polyp-derived superoxide anion: dose-dependent inhibition by nitric oxide and pathophysiological implications. Am J Respir Crit Care Med. 2001;163:1:145-151.
  14. Chen J, Xiang J. Expression of NO and NOS in nasal polyps. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2003;17:12:742-744.
  15. Winther B, Buchert D, Turner RB, Hendley JO, Tschaikin M. Decreased rhinovirus shedding after intranasal oxymetazoline application in adults with induced colds compared with intranasal saline. Am J Rhinol Allergy. 2010;24(5):374-377. doi:10.2500/ajra.2010.24.3491
  16. Olivier P, Dugué A, Montastruc JL. Adverse cardiovascular and central neurologic reactions to sympathomimetics used as nasal decongestants: results of the French National Pharmacovigilance Survey. Therapie. 2003;58(4):361-366.
  17. Cantu C, Arauz A, Murillo-Bonilla LM, López M, Barinagarrementeria F. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke. 2003;34(7):1667-1672.
  18. Margaral LE, Sandborn GE, Donoso LA, et al. Branch retinal artery occlusion after excessive use of nasal spray. Ann Ophthalmol. 1985;17:500-501.
  19. Montalban J, Rodriguez C, Lopes M, Sumalla J, Codina A. Cerebral infarction after excessive use of nasal decongestants. J Neurol Neurosurg Psychiatry. 1989;52:541-543.
  20. Onuigbo M, Alikhan M. Over-the-counter sympathomimetics: a risk factor for cardiac arrhythmias in pregnancy. South Med J. 1998;91(12):1153-1155.
  21. Fleming GA. The FDA, regulation, and the risk of stroke. N Engl J Med. 2000;343:886-1887.
  22. Mersfelder TL. Phenylpropanolamine and stroke: the study, the FDA ruling, the implications. Cleve Clin J Med. 2001;68(3):208-9, 213-9, 223.
  23. Рiskunov SZ. Funkcionalnaya diagnostika i lechenie razlichnyh form rinita: Dis. ... dokt med nauk. M. 1986
  24. Bykova VP. Dinamika kataralnogo vospaleniya: Dis. ... dokt med nauk. M. 1975.
  25. Widdicombe J. Microvascular anatomy of the nose. Allergy. 1997;2:40(suppl):7-11.
  26. Pattanaik D, Lieberman P. Vasomotor rhinitis. Curr Allergy Asthma Rep. 2010;10(2):84-91. doi:10.1007/s11882-010-0089-z
  27. Milosević D, Janosević L, Dergenc R, Vasić M. Pathologic conditions associated with drug-induced rhinitis. Srp Arh Celok Lek. 2004;132(1-2):14-17.
  28. Rizzo JA, Medeiros D, Silva AR, Sarinho E. Benzalkonium chloride and nasal mucociliary clearance: a randomized, placebo-controlled, crossover, double-blind trial. Am J Rhinol. 2006;20(3):243-247.
  29. Dorn M, Hofmann W, Knick E. Tolerance and effectiveness of oxymetazoline and xylometazoline in treatment of acute rhinitis. HNO. 2003;51(10):794-799.
  30. Marple B, Roland P, Benninger M. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg. 2004;130(1):131-141.
  31. McMahon C, Darby Y, Ryan R, Scadding G. Immediate and short-term effects of benzalkonium chloride on the human nasal mucosa in vivo. Clin Otolaryngol Allied Sci. 1997;22(4):318-322.
  32. Wang JQ, Bu GX. Studies of rhinitis medicamentosa. Chin Med J (Engl). 1991;104(1):60-63.
  33. Knipping S, Holzhausen HJ, Goetze G, Riederer A, Bloching MB. Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa. Otolaryngol Head Neck Surg. 2007;136(1):57-61.
  34. Tarchalska B, Gotlib T, Samoliński B. Rhinitis medicamentosa in cytological assessment of the nasal mucosa. Pol Merkur Lekarski. 2005;19(111):288-290.
  35. Fujihara K, Yamanaka N, Bernstein JM, Ogra PL, Hard R. Morphologic and motility changes of nasal cilia in primary culture caused by Haemophilus influenzae. Ann Otol Rhinol Laryngol. 1996;105(6):452-457.
  36. Ferguson JL, McCaffrey TV, Kern EB, Martin WJ. The effects of sinus bacteria on human ciliated nasal epithelium in vitro. Otolaryngol Head Neck Surg. 1988;98(4):299-304.
  37. Ginzel A, Illum P. Nasal mucoliliary clearance in patients with septal deviation. Rhinology. 1980;18:4:177-181.
  38. Ohashi Y, Nakai Y, Kihara S, Ikeoka H, Takano H, Imoto T. Ciliary activity in patients with nasal allergies. Eur Arch Otorhinolaryngol. 1985;242:141-147.
  39. Riechelmann H, Hafner B, Mann W. Ziliare Aktivitat und Sekrettransport bei der allergischen Reaktion der N’asenschleimhaut. Allergologie. 1992;15:224-228.
  40. Piskunov SZ. Piskunov GZ. Klinicheskaya rinologiya. M. 2002.
  41. Morinaka S, Nakamura H. Inflammatory cells in nasal mucosa and nasal polyps. Auris Nasus Larynx. 2000;27(1):59-64.
  42. Mortuaire G, de Gabory L, François M, Massé G, Bloch F, Brion N, Jankowski R. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130(3):137-144. doi:10.1016/j.anorl.2012.09.005
  43. Lin CY, Cheng PH, Fang SY. Mucosal changes in rhinitis medicamentosa. Ann Otol Rhinol Laryngol. 2004;113(2):147-151.
  44. Yoo JK, Seikaly H, Calhoun KH. Extended use of topical nasal decongestants. Laryngoscope. 1997;107(1):40-43.
  45. Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Rhinology. 2003;41(3):167-174.
  46. Graf P, Juto JE. Histamine sensitivity in the nasal mucosa during four-week use of oxymetazoline. Rhinology. 1994;32:123-126.
  47. Suh SH, Chon KM, Min YG, Jeong CH, Hong SH. Effects of topical nasal decongestants on histology of nasal respiratory mucosa in rabbits. Acta Otolaryngol. 1995;115(5):664-671.
  48. Graf P. Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Rhinology. 1996;34:9-13.
  49. Tas A, Yagiz R, Yalcin O, Uzun C, Huseyinova G, Adali MK, Karasalihoglu AR. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study. Otolaryngol Head Neck Surg. 2005;132(4):608-612.
  50. Elwany S, Abdel-Salaam S. Treatment of rhinitis medicamentosa with fluticasone propionate — an experimental study. Eur Arch Otorhinolaryngol. 2001;258(3):116-119.
  51. Hallén H, Enerdal J, Graf P. Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa. Clin Exp Allergy. 1997;27(5):552-558.
  52. Alberti Dzh, Stol V. The effect of antiallergic drugs of intranasal application on the frequency of ciliary oscillation in the ciliated epithelium of the human nasal cavity in vitro. Lechashchij vrach. 2012;2:51-55.
  53. Cervin A, Andersson M. Intranasal steroids and septum perforation--an overlooked complication? A description of the course of events and a discussion of the causes. Rhinology. 1998;36(3):128-312.
  54. Kushnir NM. The role of decongestants, cromolyn, guafenesin, saline washes, capsaicin, leukotriene antagonists, and other treatments on rhinitis. Immunol Allergy Clin North Am. 2011;31(3):601-617. doi:10.1016/j.iac.2011.05.008
  55. Kern J, Bielory L. Complementary and alternative therapy (CAM) in the treatment of allergic rhinitis. Curr Allergy Asthma Rep. 2014;14(12):479. doi:10.1007/s11882-014-0479-8
  56. Eccles R, Martensson K, Chen SC. Effects of intranasal xylometazoline, alone or in combination with ipratropium, in patients with common cold. Curr Med Res Opin. 2010;26(4):889-899. doi:10.1185/03007991003648015
  57. Bende M. The effect of topical decongestant on blood flow in normal and infected nasal mucosa. Acta Otolaryngol. 1983;96(5-6):523-527.
  58. Radcig EYu. Complex homeopathic remedies for the treatment of various types of rhinitis. RMZH. 2007;2:152.
  59. Ammerschläger H, Klein P, Weiser M, Oberbaum M. Treatment of inflammatory diseases of the upper respiratory tract — comparison of a homeopathic complex remedy with xylometazoline. Forsch Komplementarmed Klass Naturheilkd. 2005;12(1):24-31.
  60. Izvin AI. The use of homeopathic drugs in the prevention of recurrence of polyposis sinusitis. Rossijskaya rinologiya. 1997;2:40.
  61. Piskunov GZ. Experience in the use of cinnabsin in the treatment of acute and chronic sinusitis. Rossijskaya rinologiya. 1998;2:40.
  62. Tulebaev RK. Pshenichnyi s i ahetov a a kompleksnoe lechenie hronicheskogo rinosinusita mineralnoi vodoi mai balyk i preparatom cinnabsin. XI z’izd otorinolaringologov ukraini, 17—19 travnya. Sudak. 2010;209-210.
  63. Soldatov IB, Shpigel AS, Pshenicyna GK, Osipov LB. The use of antihomotoxic agents in the treatment of vasomotor rhinitis. Rossijskaya rinologiya. 1997;2:49.
  64. Wiesenauer M, Häussler S, Gaus W. Pollinosis therapy with Galphimia glauca. Fortschr Med. 1983;101(17):811-814.
  65. Rybalko IA, Ulyanov IA, Rubcov KA. Lechenie medikamentoznogo rinita v ambulatornoi praktike otorinolaringologa. XI z’izd otorinolaringologov Ukraini. Sudak. 2010;174-175
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.